CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 4 Grant or award Director acquired 54,347 shares (grant or award)
- 4 Grant or award Director acquired 54,347 shares (grant or award)
- 4 Grant or award Director acquired 54,347 shares (grant or award)
- 4 Grant or award Director acquired 54,347 shares (grant or award)
- 4 Grant or award Director acquired 54,347 shares (grant or award)
- 4 Grant or award Director acquired 54,347 shares (grant or award)
- 4 Grant or award Director acquired 54,347 shares (grant or award)
- 4 Grant or award Director acquired 54,347 shares (grant or award)
- 4 Grant or award Director acquired 54,347 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- CERT Other Certification
- 8-K Event Material agreement · Shareholder rights changed · Regulation FD disclosure
- 8-A12B Other Registration of Securities
Page 7 of 121 · 2,419 filings